Schlagwort: disease
It’s time to focus on cardiovascular diseases!
To no one’s surprise, the oncology sector dominates the top deals in biopharma year by year. The industry simply ‘knows’ how to develop novel...
Can biopharma’s drug-focused R&D strategy remain profitable?
Since the 1990s, there has been a shift in focus within pharmaceutical R&D. It resulted in placing greater emphasis on areas such as cancer,...